Search results
Results from the WOW.Com Content Network
It also licensed out a new diabetes drug to the German Merck. [3] For the financial year 2016–2017 its sales were around 81 billion INR (ca. $1.25 billion), making it the fourth-biggest Indian pharmaceutical company. [12] In May 2019, Yasir Rawjee was elected as CEO of Glenmark Life Sciences. [13]
This is a list of tables showing the historical timeline of the exchange rate for the Indian rupee (INR) against the special drawing rights unit (SDR), United States dollar (USD), pound sterling (GBP), Deutsche mark (DM), euro (EUR) and Japanese yen (JPY). The rupee was worth one shilling and sixpence in sterling in 1947.
As of 2024, Japan's foreign exchange reserves are typically around $1.2 trillion to $1.3 trillion, making Japan one of the largest holders of reserves globally, second only to China. Japan's reserves are diversified and consist of a mix of foreign currency assets (such as US dollars, euros, and other major currencies), government bonds, gold ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Officially, the Indian rupee has a market-determined exchange rate. However, the Reserve Bank of India trades actively in the USD/INR currency market to impact effective exchange rates. Thus, the currency regime in place for the Indian rupee with respect to the US dollar is a de facto controlled exchange rate.
The NAP seeks to provide a holistic approach to a diabetic treatment for patients and their families. [57] The i3-diabetes programme is a collaboration between the King's Health Partners, one of only six Academic Health Sciences Centres (AHSCs) in England, and Novo Nordisk. The programme is a five-year collaboration designed to deliver ...
In October 2016, Teva has sold off part of its UK and Ireland generic business to Indian pharmaceutical company Intas Pharma for 600 million pounds (5083 crore Indian rupees) in cash. [79] In August 2016, Australia pharmaceutical company Mayne Pharmaceutical bought a portfolio of drugs from pharmaceutical giant Teva Pharmaceuticals last year ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us